Targeted treatment after chemo for certain breast cancers
Part of Cancer, Skin clinical trials.
This trial studies an additional treatment given after chemotherapy for locally advanced breast cancer that has spread to specific underarm lymph nodes. It may help some people reduce cancer returning, especially when tumors match certain growth and spread features.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your breast cancer has spread to underarm (axillary) lymph nodes, confirmed under a microscope
- Your scan/ultrasound at diagnosis showed at least 4 suspicious underarm lymph nodes (N2a)
- Your original tumor was larger/locally advanced in a way that required removal of underarm lymph nodes (T4 as defined by the study team)
- You have already completed neoadjuvant chemotherapy (chemo given before surgery)
- Your cancer is not in the “luminal A” subtype (based on lab/molecular testing by the study)
- You do not have scans showing more advanced lymph-node spread (cN3) or internal mammary involvement (N2b)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat the underarm lymph nodes in people whose sentinel lymph node still shows limited cancer after chemotherapy and hormone treatment. It may help find which approach controls cancer better with fewer side effects.
This study tests a more focused surgery approach to remove lymph nodes in the armpit for people with early breast cancer that has been found in 1–2 axillary lymph nodes. It may help guide more precise treatment while checking how well this approach works.
This study looks at whether it’s safe and effective to avoid removing many underarm lymph nodes in some people who, after chemotherapy, still seem to have only tiny (“micro”) cancer deposits in the sentinel lymph node. It may help reduce treatment side effects while keeping cancer control.
This trial is for women age 45 and older with early ER-positive breast cancer that has spread to the lymph nodes under the arm. It tests a surgery approach where the main tumor and only a few key lymph nodes (rather than many) are removed.
This trial compares two treatments for people with breast cancer that has spread to the lymph nodes: radiation therapy to the armpit or surgery to remove the lymph nodes. The goal is to see which approach works best after a tailored surgery to remove the most suspicious lymph nodes.
This trial studies how doctors should operate on lymph nodes after you finish chemotherapy given before surgery. It may help improve treatment planning for people whose breast cancer has spread to nearby lymph nodes, but not to distant organs.
Hear when a new Sentinel Lymph Node trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.